Work

Abstract 6155: The combination of cisplatin and temozolomide triggers immune surveillance through antigen-dependent and independent mechanisms

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-6155

Authors: Pietro Paolo Vitiello, Rosaria Chila, Vito Amodio, Paolo Battuello, Vittorio Battaglieri, Sharon Scardellato, Gaia Grasso, Federica Pisati, Claudio Tripodo, Achille Anselmo, Francesca Clemente, Federica Di Nicolantonio, Giovanni Crisafulli, Benoit Rousseau, Luis A. Diaz, Giovanni Germano, Alberto Bardelli

Institutions: University of Turin, IFOM, Cogentech S.R.L. Società Benefit a Socio Unico soggetta all’attività di direzione e coordinamento di IFOM - Istituto Fondazione di Oncologia Molecolare ETS (Italy), IRCCS Ospedale San Raffaele, Memorial Sloan Kettering Cancer Center, University of Milan

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409628111

Cites:

Cited by:

Related to: 10